Crossreactivity of antibodies to canine CD25 and Foxp3 and identification of canine CD4+CD25+Foxp3+ cells in canine peripheral blood

Journal of Veterinary Medical Science

Volumn 71, Issue 12, 2009, Pages 1561-1568

  Mizuno, Takuya ^a   Suzuki, Ryoichi ^a   Umeki, Saori ^a   Okuda, Masaru ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Canine; CD25; Foxp3; Treg

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CONCANAVALIN A; FORKHEAD TRANSCRIPTION FACTOR; INTERLEUKIN 2 RECEPTOR ALPHA;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BLOOD; CELL CULTURE; DOG; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIGENS, CD4; BASE SEQUENCE; CELLS, CULTURED; CONCANAVALIN A; DOGS; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 73349134700     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.001561     Document Type: Article

References (21)

1. Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G. and Levings, M. K. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19: 345-354.
2. Bacchetta, R., Passerini, L., Gambineri, E., Dai, M., Allan, S. E., Perroni, L., Dagna-Bricarelli, F., Sartirana, C., Matthes-Martin, S., Lawitschka, A., Azzari, C., Ziegler, S. F., Levings, M. K. and Roncarolo, M. G. 2006. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116: 1713-1722.
3. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F. and Ochs, H. D. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27: 20-21.
4. Biller, B. J., Elmslie, R. E., Burnett, R. C., Avery, A. C. and Dow, S. W. 2007. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Vet. Immunol. Immunopathol. 116: 69-78.
5. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., Wilkinson, J. E., Galas, D., Ziegler, S. F. and Ramsdell, F. 2001. Disruption of a new fork-head/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73.
6. Chen, W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marinos, N., McGrady, G. and Wahl, S. M. 2003. Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
7. Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4: 330-336.
8. Galkowska, H., Waldemar, L. O. and Wojewodzka, U. 1996. Reactivity of antibodies directed against human antigens with surface markers on canine leukocytes. Vet. Immunol. Immunopathol. 53: 329-334.
9. Hori, S., Nomura, T. and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299: 1057-1061.
10. Keppel, K. E., Campbell, K. L., Zuckermann, F. A., Greeley, E. A., Schaeffer, D. J. and Husmann, R. J. 2008. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergenspecific immunotherapy. Vet. Immunol. Immunopathol. 123: 337-344.
11. Kitamura, T., Koshino, Y., Shibata, F., Oki, T., Nakajima, H., Nosaka, T. and Kumagai, H. 2003. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 31: 1007-1014.
12. Masuda, K. and Yasuda, N. 2008. The antibody against human CD25, ACT-1, recognizes canine T-lymphocytes in the G2/M and G0/G1 phases of the cell cycle during proliferation. J. Vet. Med. Sci. 70: 1285-1287.
13. Morgan, M. E., van Bilsen, J. H., Bakker, A. M., Heemskerk, B., Schilham, M. W., Hartgers, F. C., Elferink, B. G., van der Zanden, L., de Vries, R. R., Huizinga, T. W., Ottenhoff, T. H. and Toes, R. E. 2005. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum. Immunol. 66: 13-20.
14. Pillai, V., S. Ortega, B., Wang, C. K. and Karandikar, N. J. 2007. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin. Immunol. 123: 18-29.
15. Selvaraj, R. K. and Geiger, T. L. 2007. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J. Immunol. 178: 7667-7677.
16. Vignali, D. A., Collison, L. W. and Workman, C. J. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
17. Wang, J., Ioan-Facsinay, A., van der Voort, E. I., Huizinga, T. W. and Toes, R. E. 2007. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur. J. Immunol. 37: 129-138.
18. Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J. L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., Bricarelli, F. D., Byrne, G., McEuen, M., Proll, S., Appleby, M. and Brunkow, M. E. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27: 18-20.
19. Yamaguchi, T., Hirota, K., Nagahama, K., Ohkawa, K., Takahashi, T., Nomura, T. and Sakaguchi, S. 2007. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27: 145-159.
20. Yasuda, T., Bundo, K., Hino, A., Honda, K., Inoue, A., Shirakata, M., Osawa, M., Tamura, T., Nariuchi, H., Oda, H., Yamamoto, T. and Yamanashi, Y. 2007. Dok-1 and Dok-2 are negative regulators of T cell receptor signaling. Int. Immunol. 19: 487-495.
21. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24: 209-226.